Return of the Coronavirus: 2019-nCoV
by
Lisa E. Gralinski 1 and Vineet D. Menachery 2,3,*
Lisa E. Gralinski 1 and Vineet D. Menachery 2,3,*
1
Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC 27514, USA
2
Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA
3
Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX 77555, USA
*
Author to whom correspondence should be addressed.
Viruses 2020, 12(2), 135; https://doi.org/10.3390/v12020135
Received: 21 January 2020 / Revised: 24 January 2020 / Accepted: 24 January 2020 / Published: 24 January 2020
(This article belongs to the Special Issue Pathogenesis of Human and Animal Coronaviruses)
The emergence of a novel coronavirus (2019-nCoV) has awakened the echoes of SARS-CoV from nearly two decades ago. Yet, with technological advances and important lessons gained from previous outbreaks, perhaps the world is better equipped to deal with the most recent emergent group 2B coronavirus.
View Full-Text
Keywords:
2019-nCoV; novel CoV; Wuhan; Wuhan pneumonia; coronavirus; emerging viruses; SARS-CoV; MERS-CoV
▼
Show Figures
Figure 1
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
MDPI and ACS Style
Gralinski, L.E.; Menachery, V.D. Return of the Coronavirus: 2019-nCoV. Viruses 2020, 12, 135.
Show more citation formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
